Login    Join free Add to favorites    中文
Home > News > Postnova: EAF4 Technique Determines Attributes of Monoclonal Antibodies
Industry Updates New Products Supplier News Upcoming Events business web
Postnova: EAF4 Technique Determines Attributes of Monoclonal Antibodies
hits:111     Date:03/06/19

Postnova Analytics Inc. reports how its Electrical Asymmetrical Flow Field Flow Fractionation (EAF4) and Size Exclusion Chromatography (SEC) modules have been used to determine the physicochemical and biophysical attributes of monoclonal antibodies.

EAF4 technology uniquely combines the principle of Electrical and Asymmetrical Field Flow Fractionation in just one system. In a Postnova Analytics EAF2000 system - Electrical and Cross Flow Fields are applied simultaneously across the FFF channel enabling separation by size and simultaneous measurement of particle charge based on electrophoretic mobility. Combining these two powerful separation techniques in a single platform opens the door to characterizing complex proteins, antibodies and viruses as well as charged nanoparticles, colloids, or polymers that have proven intractable to other techniques. 

A new poster describes how the EAF4 module enabled simultaneous measurement of size and surface charge characteristics (electrophoretic mobility) of antibodies and proteins. While no aggregates were detected by SEC, the EAF4 system showed antibody aggregates represented 10% of the total mass injected. The researchers concluded that the FFF open channel design may allow for better recovery of injected mass than SEC, which is particularly important when seeking to quantify aggregates present in small amounts.

In the described work, a reference monoclonal antibody (RM 8671 mAb), from the U.S. National Institute of Standards and Technology (NIST), was used to compare separation, aggregation quantification, and recovery parameters for an EAF4-UV-MALS versus SEC-UV-MALS techniques. The NIST mAb provides a representative test molecule for development of novel technology for therapeutic protein characterization. 

For a copy of the poster and further information on the EAF2000 system please contact Postnova Analytics Inc. at +1 (801) 521-2004 / info.usa@postnova.com

Founded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company's growing product portfolio includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS Light Scattering.  Postnova Analytics Inc. is located in Salt Lake City, USA.


North American HQ 
Postnova Analytics Inc
230 South 500 East, S. #110
Salt Lake City, UT 84102
Tel: +1-801-521-2004
Related News>> more
Copyright(C) 2006-2019 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙